Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 100Leukemia 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Myelodysplastic Syndromes 17Leukemia, Monocytic, Acute 14Leukemia, Myelomonocytic, Acute 13Leukemia, Erythroblastic, Acute 12Leukemia, Megakaryoblastic, Acute 11Congenital Abnormalities 11Leukemia, Promyelocytic, Acute 9Recurrence 8Leukemia, Biphenotypic, Acute 7Carcinoma, Hepatocellular 7Leukemia, Myelomonocytic, Chronic 6Myeloproliferative Disorders 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Anemia, Refractory, with Excess of Blasts 5Lymphoma 4Blast Crisis 4Neoplasm, Residual 3Lymphoma, Large B-Cell, Diffuse 3Liver Neoplasms 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Eosinophilic, Acute 3Leukemia, Basophilic, Acute 3Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lung Neoplasms 2

Interventions

Cyclophosphamide 5pegaspargase 3Vincristine 3Methotrexate 3Mercaptopurine 3Etoposide 3Dexamethasone 3Cytarabine 3fludarabine 2Radiotherapy 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Karyotyping 2Injections, Spinal 2Idarubicin 2Doxorubicin 2nelarabine 1mogamulizumab 1Positron Emission Tomography Computed Tomography 1Panobinostat 1Mitoxantrone 1Melphalan 1Everolimus 1Clofarabine 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, T-Cell × Idarubicin × Clear all
NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
80 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03553238 2018-06-12

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
70 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡